Ardent Health Partners (NYSE:ARDT) Lowered to “Neutral” Rating by Bank of America

Bank of America lowered shares of Ardent Health Partners (NYSE:ARDT) from a buy rating to a neutral rating in a research report report published on Wednesday, MarketBeat.com reports. The firm currently has $19.00 price target on the stock, down from their previous price target of $22.00.

Several other equities analysts have also weighed in on ARDT. Loop Capital initiated coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $18.00 price target for the company. Morgan Stanley started coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set an “overweight” rating and a $27.00 price target for the company. JPMorgan Chase & Co. started coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a “neutral” rating and a $18.00 target price for the company. KeyCorp started coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an “overweight” rating and a $24.00 target price for the company. Finally, Truist Financial started coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $21.00 target price for the company. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Ardent Health Partners presently has a consensus rating of “Buy” and a consensus price target of $21.64.

Ardent Health Partners Trading Down 6.7 %

Shares of ARDT stock opened at $16.37 on Wednesday. The firm has a 50-day moving average price of $18.42. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.65 and a quick ratio of 1.54. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.05. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.46 billion. On average, sell-side analysts forecast that Ardent Health Partners will post 1.26 EPS for the current year.

Institutional Trading of Ardent Health Partners

Hedge funds have recently modified their holdings of the business. Financial Management Professionals Inc. purchased a new position in shares of Ardent Health Partners in the 3rd quarter worth about $50,000. Seven Grand Managers LLC purchased a new position in Ardent Health Partners in the 3rd quarter worth about $2,298,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in Ardent Health Partners in the 3rd quarter worth about $13,119,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.